-
Scientists announce important Zika milestone: First vaccine ready for human trials
Pennsylvania vaccine maker Inovio Pharmaceuticals and South Korea’s GeneOne Life Sciences said Monday that they had received approval from U.S. regulators to start testing a DNA vaccine, known as GLS-5700, on humans.
- Categories
- Health Care
-
‘Disease outbreak guarantees’—A proposed mechanism for enhancing public health capacity
The possible path to offering disease outbreak guarantees is an idea being posed by two global health researchers who suggest that a mechanism for establishing such an instrument could be tied to public health investments.
- Categories
- Health Care
-
With Another Pandemic Looming, Let’s Change Perspective
We cannot prevent the emergence of new viruses, according to Dr. Melvin Sanicas, a Global Health Fellow and program officer at the Bill & Melinda Gates Foundation, but we can take measures to prevent small epidemics from becoming big ones, including investing in infrastructures for preparedness.
- Categories
- Health Care
-
Why the Vaccination Supply Chain Needs Reform
I recently returned from a week in Mozambique with a goal of learning about new immunization supply chain models and observing their impact. I also wanted to better understand opportunities and constraints for taking this work to scale -- in Mozambique and across other Gavi-eligible countries.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- supply chains, vaccines
-
Behind the World’s Top Drugmakers’ Approach to Zika Vaccine
What if a drugmaker spent billions of dollars to create a vaccine -- only to find out humans developed natural resistance to the disease before its product is ready?
- Categories
- Health Care
- Region
- Latin America
- Tags
- vaccines
-
For Struggling Pharma Market, Vaccines Offer Path to Revenue
The revenue growth opportunity in vaccines looks far more promising when compared to the overall market for pharmaceuticals. Revenues earned by vaccines manufacturers worldwide reached $27.6 billion in 2015 according to Kalorama Information, up 11% from $24.7 billion in 2014, as sales in all segments expanded (Figure 1). This is, by Kalorama’s estimate, at least five to ten times the revenue growth rate of the overall pharmaceutical market in recent years. The world vaccines market is predicted to increase at a compound annual rate of 7.6% during 2013–2022, reaching $45.1 billion in 2022 as new product introductions continue and usage of current products expands further.
- Categories
- Health Care
- Tags
- vaccines
-
Self-Injectable Contraceptives Could Be Life-Saver in Africa – Health Experts
Self-injectable contraceptives, which are being trialled in Uganda and Senegal, could revolutionise women's lives in rural Africa and dramatically cut maternal and newborn deaths, health experts said on Tuesday.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines
-
New HIV Vaccine Will be Tested in South Africa
An experimental AIDS vaccine that's worked better than anything else tried so far is going to be tested in South Africa, U.S. health officials said Wednesday.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
- Tags
- vaccines